ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,886.54
-0.29%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ProPhase Labs Inc (PRPH)

  7. ProPhase Labs Inc (PRPH) News

ProPhase Labs (PRPH)

ProPhase Labs Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRPH
DateTimeSourceHeadlineSymbolCompany
10/05/202421:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPHProPhase Labs Inc
09/05/202422:08Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PRPHProPhase Labs Inc
09/05/202420:40GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - UpdatedNASDAQ:PRPHProPhase Labs Inc
09/05/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPHProPhase Labs Inc
09/05/202413:00Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PRPHProPhase Labs Inc
09/05/202413:00GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.NASDAQ:PRPHProPhase Labs Inc
02/05/202413:00GlobeNewswire Inc.PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9NASDAQ:PRPHProPhase Labs Inc
25/04/202413:00GlobeNewswire Inc.ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024NASDAQ:PRPHProPhase Labs Inc
16/04/202413:00GlobeNewswire Inc.ProPhase Labs Unveils Project ZenQ-AINASDAQ:PRPHProPhase Labs Inc
10/04/202413:00GlobeNewswire Inc.ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024NASDAQ:PRPHProPhase Labs Inc
02/04/202402:00GlobeNewswire Inc.ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRPHProPhase Labs Inc
15/03/202412:00GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic InitiativesNASDAQ:PRPHProPhase Labs Inc
08/03/202413:00GlobeNewswire Inc.PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024NASDAQ:PRPHProPhase Labs Inc
20/02/202413:00GlobeNewswire Inc.ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMARTNASDAQ:PRPHProPhase Labs Inc
14/02/202421:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRPHProPhase Labs Inc
14/02/202413:00GlobeNewswire Inc.ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement EquivirNASDAQ:PRPHProPhase Labs Inc
30/01/202413:00GlobeNewswire Inc.ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula GenomicsNASDAQ:PRPHProPhase Labs Inc
23/01/202413:00GlobeNewswire Inc.Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New ContractsNASDAQ:PRPHProPhase Labs Inc
04/01/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPHProPhase Labs Inc
04/01/202413:00GlobeNewswire Inc.ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024NASDAQ:PRPHProPhase Labs Inc
13/11/202321:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPHProPhase Labs Inc
09/11/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPHProPhase Labs Inc
09/11/202313:00GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023NASDAQ:PRPHProPhase Labs Inc
02/11/202312:00GlobeNewswire Inc.ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern TimeNASDAQ:PRPHProPhase Labs Inc
17/10/202313:00GlobeNewswire Inc.ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.NASDAQ:PRPHProPhase Labs Inc
12/10/202313:25GlobeNewswire Inc.DSS Inc. Issues Letter to ShareholdersNASDAQ:PRPHProPhase Labs Inc
12/10/202313:00GlobeNewswire Inc.ProPhase Labs to Present at The ThinkEquity ConferenceNASDAQ:PRPHProPhase Labs Inc
11/08/202321:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPHProPhase Labs Inc
10/08/202315:40GlobeNewswire Inc.ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.NASDAQ:PRPHProPhase Labs Inc
10/08/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPHProPhase Labs Inc
 Showing the most relevant articles for your search:NASDAQ:PRPH

Your Recent History

COIN
SYNCUSD
SYNC
LATK
S4FBTC
S4FE
AMEX
PSI
Invesco Semiconductors ETF
COIN
DRPEUR
DCORP
TSXV
NDX
BIT
UC564Y
Unicredit Bank
LSE
TRAC
T42 Iot Tracking Solutions
COIN
BLCUSD
COIN
VTLAGBP
TSX
ESGY
BMO MSCI USA ESG Leaders...
LSE
LST
Light Science Technologies
COIN
BUXEUR
BUX Token
COIN
SPINBTC
BIT
P17UZ2
BNP Paribas Issuance
ASX
BSNN
LBNK
FLMUSDT
Flamingo
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved